Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

FDA Approves Lumisight (pegulicianine) Optical Imaging Agent to Illuminate Residual Breast Cancer Post-Lumpectomy

(BUSINESS WIRE) April 18, 2024 --Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging technologies for...

FDA Approves Selarsdi (ustekinumab-aekn), a Biosimilar to Stelara

(BUSINESS WIRE) April 16, 2024 --Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE:...

Calories, Not Meal Timing, Key to Weight Loss: Study

A head-to-head trial of obese, pre-diabetic people who ate the same amount of daily calories -- with one group following a fasting schedule and the other...

Dietary Changes May Beat Meds in Treating IBS

The right diet may be the best medicine for easing the painful symptoms of irritable bowel syndrome (IBS), new research shows. In the study, two different...

Screen Pregnant Women for Syphilis, Ob-Gyn Group Advises

All expecting mothers should get a blood test for syphilis three times during pregnancy, new guidance issued by the American College of Obstetricians and...

Even With Weight Gain, Quitting Smoking in Pregnancy Still Best for Health

Women who smoke and become pregnant may worry that the weight gain that comes with quitting might bring its own harms to themselves or their baby.However,...

AskBio Receives FDA Fast Track Designation for AB-1002 Investigational Gene Therapy Program in Congestive Heart Failure

Berlin, Germany, and Research Triangle Park, NC, USA, April 18, 2024 – Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company...

NIH Researchers Develop AI Tool with Potential to More Precisely Match Cancer Drugs to Patients

In a proof-of-concept study, researchers at the National Institutes of Health (NIH) have developed an artificial intelligence (AI) tool that uses data...

Daily Heat-Related Illness ED Visit Rates Peaked in 2023 Warm Season

Daily heat-related illness (HRI) emergency department visit rates peaked in the 2023 warm season months, according to research published in the April 18...

American Association for Cancer Research, April 5-10

The annual meeting of the American Association for Cancer Research was held this year from April 5 to 10 in San Diego, drawing approximately 19,000 participants...

Salmonella Linked to Trader Joe's Fresh Basil Sickens 12

The U.S. Centers for Disease Control and Prevention warns of possible Salmonella contamination of Trader Joe's fresh organic basil sold in 29 states. Twelve...

High Levels of Pesticides Found in 20 Percent of Fruits, Vegetables

Nearly one-fifth of fresh, frozen, and canned fruits and vegetables that Americans eat contain concerning levels of pesticides, posing significant risks...

Walking Your Way to Better Health

Walking is one of the best exercises available to average folks, and it can be as easy as stepping out your front door, experts say. “It is something...

Counterfeit Versions of Botox Found in Multiple States

 FDA is alerting health care professionals and consumers that unsafe counterfeit versions of Botox (botulinum toxin) have been found in multiple states...

Read more news...

Recently Added

Recently added consumer and prescribing information: Risvan, Voydeya, Winrevair, Pemgarda, Tryvio, Edurant and Edurant Ped, Tevimbra, Rezdiffra, Tyenne, Wyost

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Lumisight Lumisight (pegulicianine) is an optical imaging agent for the detection of residual cancerous tissue during breast cancer surgery.
  • Selarsdi Selarsdi (ustekinumab-aekn) is a human interleukin-12 and -23 antagonist biosimilar to Stelara used for the treatment of plaque psoriasis...
  • Zevtera Zevtera (ceftobiprole medocaril) is a cephalosporin antibiotic for the treatment of bacteremia, acute bacterial skin and skin structure...

More FDA approvals

Drugs in Development (Not yet approved)

  • Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...
  • Libervant Libervant (diazepam) is a buccal film formulation of the approved benzodiazepine diazepam in development for the management of seizure clusters.

More drugs in development